Recurrent disability progression endpoints in multiple sclerosis clinical trials

por Bühler, Alexandra, Wolbers, Marcel, Model, Fabian, Wang, Qing, Belachew, Shibeshih, Manfrini, Marianna, Lorscheider, Johannes, Kappos, Ludwig, Beyersmann, Jan
Publicado 2022

Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO

por Gibiansky, Ekaterina, Petry, Claire, Mercier, Francois, Günther, Andreas, Herman, Ann, Kappos, Ludwig, Hauser, Stephen, Yamamoto, Yumi, Wang, Qing, Model, Fabian, Kletzl, Heidemarie
Publicado 2020

Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis

por Elliott, Colm, Belachew, Shibeshih, Wolinsky, Jerry S, Hauser, Stephen L, Kappos, Ludwig, Barkhof, Frederik, Bernasconi, Corrado, Fecker, Julian, Model, Fabian, Wei, Wei, Arnold, Douglas L
Publicado 2019

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Ana...

por Kappos, Ludwig, Wolinsky, Jerry S., Giovannoni, Gavin, Arnold, Douglas L., Wang, Qing, Bernasconi, Corrado, Model, Fabian, Koendgen, Harold, Manfrini, Marianna, Belachew, Shibeshih, Hauser, Stephen L.
Publicado 2020

Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis

por Hauser, Stephen L., Bar-Or, Amit, Weber, Martin S., Kletzl, Heidemarie, Günther, Andreas, Manfrini, Marianna, Model, Fabian, Mercier, Francois, Petry, Claire, Wing, Qing, Koendgen, Harold, Smith, Terence, Kappos, Ludwig
Publicado 2023

Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension

por Hauser, Stephen L., Kappos, Ludwig, Arnold, Douglas L., Bar-Or, Amit, Brochet, Bruno, Naismith, Robert T., Traboulsee, Anthony, Wolinsky, Jerry S., Belachew, Shibeshih, Koendgen, Harold, Levesque, Victoria, Manfrini, Marianna, Model, Fabian, Hubeaux, Stanislas, Mehta, Lahar, Montalban, Xavier
Publicado 2020

Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizuma...

por Bar-Or, Amit, Thanei, Gian-Andrea, Harp, Christopher, Bernasconi, Corrado, Bonati, Ulrike, Cross, Anne H., Fischer, Saloumeh, Gaetano, Laura, Hauser, Stephen L., Hendricks, Robert, Kappos, Ludwig, Kuhle, Jens, Leppert, David, Model, Fabian, Sauter, Annette, Koendgen, Harold, Jia, Xiaoming, Herman, Ann E.
Publicado 2023

Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay

por Grützmann, Robert, Molnar, Bela, Pilarsky, Christian, Habermann, Jens K., Schlag, Peter M., Saeger, Hans D., Miehlke, Stephan, Stolz, Thomas, Model, Fabian, Roblick, Uwe J., Bruch, Hans-Peter, Koch, Rainer, Liebenberg, Volker, deVos, Theo, Song, Xiaoling, Day, Robert H., Sledziewski, Andrew Z., Lofton-Day, Catherine
Publicado 2008

Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry

por Butzkueven, Helmut, Spelman, Tim, Horakova, Dana, Hughes, Stella, Solaro, Claudio, Izquierdo, Guillermo, Kubala Havrdová, Eva, Grand'Maison, Francois, Prat, Alexandre, Girard, Marc, Hupperts, Raymond, Onofrj, Marco, Lugaresi, Alessandra, Taylor, Bruce, Giovannoni, Gavin, Kappos, Ludwig, Hauser, Stephen L., Montalban, Xavier, Craveiro, Licinio, Freitas, Rita, Model, Fabian, Overell, James, Muros‐Le Rouzic, Erwan, Sauter, Annette, Wang, Qing, Wormser, David, Wolinsky, Jerry S.
Publicado 2021